Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours Β· Estimated delivery Aug 27 - Sep 1
Available at $189/month for Compounded Semaglutide Injection (from licensed 503A compounding pharmacies), the service includes access to guidance on adherence and adjustments if needed
Combination in patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment with Metformin alone, Sulfonylurea alone, Basal Insulin alone or Metformin in Combination with either Sulfonylurea or Basal Insulin In a 26-week, double-blind trial (Trial 5, NCT02827708), 324 adult patients with moderate renal impairment (eGFRCKD-EPI 30 to 59 mL/min/1.73 m2) were randomized to semaglutide tablets 14 mg orally once daily or placebo once daily
*Clinical studies show patients treated with GLP-1s experienced an average weight loss of 14.9-20.9% of their total body weight after 68-72 weeks
However, significant metabolic changes that occur during treatmentparticularly substantial weight losscould theoretically affect menstrual patterns
